Progyny (PGNY) Tops Q4 EPS by 11c, Guidance Misses Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Progyny, Inc. Announces Fourth Quarter and Full Year 2021 Results
February 28, 2022 4:05 PM ESTIssues Guidance for 2022, Reflecting 50% Revenue Growth at Midpoint of the RangeReports Full Year Revenue of $500.6 Million, Reflecting 45% GrowthReports Fourth Quarter Revenue of $127.6 Million, Reflecting 27% Growth
NEW YORK, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its financial results for the three- and twelve-month periods ended December 31, 2021 (the fourth quarter of 2021 and the full year, respectively) as compared to the three- and twelve-month periods ended December 31, 2020 (the fourth quarter of 2020 and the prior year period,... More
